Mckesson Technologies, Inc.

McKesson Technologies, Inc. specializes in developing anaesthesia information system application software. These digital tools are designed to streamline and document anaesthesia care workflows, including patient monitoring, medication records, and procedural tracking in clinical environments. The focus is on software solutions rather than hardware.

McKesson Technologies, Inc. is based in the United States. Since the company’s devices are regulated by the FDA, their classification and compliance processes follow U.S. medical device regulations. The location also influences which registries (like the 510(k) and UDI databases) are relevant for tracking their authorised products.

McKesson Technologies, Inc.’s devices are listed in the FDA’s 510(k) and UDI registries. The 510(k) registry tracks premarket submissions for Class II devices to demonstrate substantial equivalence to existing authorised products, while the UDI system ensures unique identification and traceability of devices throughout their lifecycle. Both registries are critical for compliance and transparency in the U.S. market.

McKesson Technologies, Inc.’s anaesthesia information system software is classified as FDA Class II devices. This classification applies because the software directly impacts patient safety and clinical workflows—such as medication administration and procedural documentation—requiring special controls to mitigate risks. Class II designation means these devices undergo premarket notifications (510(k)) to ensure they meet regulatory standards before entering the market.